Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-23 ADAMIS ANTHONY P Director Grant or award · Restricted Stock Units +6,000 6,000
2022-06-23 ADAMIS ANTHONY P Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2022-03-14 Pine Michael Craig Chief Corp Dev.&Strat. Officer Purchase +1,000 $12.21 $12K 1,000
2022-02-28 Jones David Scott SVP & Chief Commercial Officer Option exercise +4,105 16,729
2022-02-28 Jones David Scott SVP & Chief Commercial Officer Shares withheld for taxes −1,130 $9.95 $11K 15,599
2022-02-28 Jones David Scott SVP & Chief Commercial Officer Option exercise · Restricted Stock Units −4,105 0
2022-02-28 Paggiarino Dario A. Chief Medical Officer Option exercise +4,105 19,945
2022-02-28 Paggiarino Dario A. Chief Medical Officer Shares withheld for taxes −1,294 $9.95 $13K 18,651
2022-02-28 Paggiarino Dario A. Chief Medical Officer Option exercise · Restricted Stock Units −4,105 0
2022-02-28 Lurker Nancy President & CEO Option exercise +12,466 150,281
2022-02-28 Lurker Nancy President & CEO Option exercise · Restricted Stock Units −12,466 0
2022-02-21 Lurker Nancy President & CEO Option exercise +13,717 137,815
2022-02-21 Lurker Nancy President & CEO Option exercise · Restricted Stock Units −13,717 13,718
2022-02-09 Landis John B. Director Option exercise +2,500 8,400
2022-02-09 Landis John B. Director Option exercise · Restricted Stock Units −2,500 0
2022-02-09 Landis John B. Director Grant or award · Restricted Stock Units +3,000 3,000
2022-02-09 Landis John B. Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2022-02-09 GUYER DAVID R Director Option exercise +2,500 4,400
2022-02-09 GUYER DAVID R Director Option exercise · Restricted Stock Units −2,500 0
2022-02-09 GUYER DAVID R Director Grant or award · Restricted Stock Units +3,000 3,000

Page 27 of 31 · 616 trades